← SynDRA
LEXIBULIN
SynDRA canonical compound SYN0019622 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TUBB |
|---|
| Mechanism of action | Tubulin inhibitor |
|---|
All known targets
- TUBB
- TUBA1A
- TUBA1B
- TUBA1C
- TUBA3C
- TUBA3E
- TUBA4A
- TUBB1
- TUBB2A
- TUBB2B
- TUBB3
- TUBB4A
Mechanisms of action (all sources)
- microtubule inhibitor
- TUBB4B INHIBITOR
- TUBB1 INHIBITOR
- TUBA3C INHIBITOR
- TUBA4A INHIBITOR
- TUBB3 INHIBITOR
- TUBA1A INHIBITOR
- TUBB4A INHIBITOR
- TUBB8 INHIBITOR
- TUBB INHIBITOR
- TUBA1B INHIBITOR
- TUBA1C INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Lexibuline
- Lexibulina
- CYT-997
- CYT997
- Microtubule inhibitor (oral, solid tumors) Cytopia
- VDA anticancer program (iv), Cytopia
- Lexibulin (iv infusion, cancer), YM BioSciences
- Lexibulin (oral capsule, cancer), YM Biosciences
- CYT-997 (iv infusion, cancer), Cytopia
- CYT-997 (iv infusion, cancer), YM BioSciences
- CYT-997 (oral capsule, cancer), Cytopia
- CYT-997 (oral capsule, cancer), YM Biosciences
- Vascular disrupting agent/ tubulin inhibitor (iv, cancer), Cytopia
- Vascular disrupting agent/tubulin inhibitor (oral, cancer), Cytopia
- Vascular targeting agent/ tubulin inhibitor (iv, cancer), Cytopia
- CYT 997
- lexibulina
- lexibuline
- 2GTU230HA1
- lexibulinum
- RefChem:153245
- Tubulin Inhibitor CYT997
- DTXCID60161166
- CYT997 (Lexibulin)
- lexibulin (CYT997)
- Lexibulin (USAN)
- Lexibulin hydrochloride
- LEXIBULIN [USAN]
- Lexibulin [INN]
- Lexibulin [USAN:INN]
- UNII-2GTU230HA1
- MFCD18206787
- CYT997(Lexibulin)
- Lexibulin; CYT-997
- Cyr997
- LEXIBULIN [WHO-DD]
- MLS006011265
- orb1306503
- SCHEMBL1122311
Look up LEXIBULIN in the interactive SynDRA portal →